Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-622P represents a pseudogene belonging to the U6 small nuclear RNA gene family. U6 snRNA is a highly conserved, essential component of spliceosomal snRNPs in eukaryotic cells, forming part of the core machinery for pre-mRNA intron removal[1][3]. Numerous pseudogenes derived from U6 snRNA exist throughout vertebrate genomes, likely reflecting the evolutionary importance of the parent gene[1][4]. Such pseudogenes generally do not encode functional products or participate in canonical RNA splicing, and their biological roles remain limited or secondary. RNU6-622P is not an established therapeutic target, receptor, or protein of interest in drug discovery or clinical medicine[2].\n\nIf you seek structured information for a functional target, refer to “U6 small nuclear RNA” (U6 snRNA), not the RNU6-622P pseudogene.
None applicable, as pseudogenes are not pharmacologically targeted.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 622, pseudogene (RNU6-622P).